Correlative analyses of patient and clinical characteristics associated with efficacy in tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma patients in the JULIET trial

J Westin, CS Tam, P Borchmann, U Jaeger, JP McGuirk, H Holte, EK Waller, S Jaglowski, MR Bishop, C Andreadis, SR Foley, I Fleury, PJ Ho, S Mielke, T Teshima, SJ Schuster, V Bachanova, RT Maziarz, K Besien, K Izutsu Show all